"S2-4 STRATEGIC PROPOSALS FOR AVOIDING TOXIC INTERACTIONS WITH DRUGS FOR CLINICAL USE DURING DEVELOPMENT AND AFTER MARKETING OF A NEW DRUG : PHARMACOKINETIC CONSIDERATION (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development

スポンサーリンク

概要

著者

関連論文

もっと見る

スポンサーリンク